At this time, the company appears to be overvalued. Reata Pharmaceuticals holds a recent Real Value of $ per share. The prevailing price of the company is. Reata Pharmaceuticals DB:2R3 Stock Report ; DB · 2R3 Stock Report ; Rewards. Trading at % below our estimate of its fair value · Earnings are forecast to grow. Reata Pharmaceuticals DB:2R3 Stock Report ; DB · 2R3 Stock Report ; Rewards. Trading at % below our estimate of its fair value · Earnings are forecast to grow. The share price as of September 25, is / share. Previously, on August 24, , the share price was / share. This represents an increase of. Stock price target for Reata Pharmaceuticals, Inc. RETA are on downside and on upside. Stock price target for Reata Pharmaceuticals, Inc. RETA are.
We currently expect the initial public offering price to be between $ and $ per share of Class A common stock. We have granted the underwriters an. Reata Pharmaceuticals Inc Forecast, Short-Term " RETA" Stock Price Prognosis for Next Days · RETA Forecast, Long-Term Price Predictions for Next Months and Year. The Reata Pharmaceuticals Inc stock price today is What Is the Stock Symbol for Reata Pharmaceuticals Inc? The stock ticker symbol for Reata. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The. Analyst. Target Price. USD. 9 analysts ; Earnings. EPS Estimate. Due 8 Nov ; Financials. Valuation. HighP/S · x. Revenue Estimate. Reata Pharmaceuticals Inc For the last 8 years the compound annual growth rate for Reata Pharmaceuticals Inc's revenue is %. The. Reata Pharmaceuticals, Inc. (NASDAQ:RETA) released its quarterly earnings results on Monday, November, 8th. The company reported ($) earnings per share (EPS). Monitor the latest movements within the Reata Pharmaceuticals Inc real time stock price chart below. What Is the Reata Pharmaceuticals Inc Stock Price Today? Reata Pharmaceuticals (RETA) has a Smart Score of 1 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Reata Pharmaceuticals is at this time traded for The entity stock is not elastic to its hype. The average elasticity to hype of competition is Technical analysis forecast of Reata Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock.
Discover all the factors affecting Reata Pharmaceuticals's share price. RETA is currently rated as a null | Stockopedia. Reata Pharma stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The Reata Pharmaceuticals stock prediction for is currently $ , assuming that Reata Pharmaceuticals shares will continue growing at the average. price objective on shares of Reata Pharmaceuticals in a report on Tuesday. Reata Pharmaceuticals, Inc. stock logo. August 11, | lubertsi-beeline.online Biondo. Our Reata Pharmaceuticals Inc stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. of $ (%) on RETA (REATA PHARMACEUTICALS). Analysts Stocks. Madhu ABUS Stock Forecast and Ratings Chart. ABUS. Kelly Frozen Dataviz Dark. Reata Pharmaceuticals (RETA) Stock Has 49% Chance Of Rise In The Next One Month. Reata Pharmaceuticals (RETA) Stock Has 59% Chance Of Rise In. Reata Pharmaceuticals Inc (RETA) Stock Price Prediction, Stock Forecast for next months and years ; August , Open: , Close: , Min: , Max. (RETA) stock forecast for tomorrow and next week. Stay ahead of the game with our Reata Pharmaceuticals stock price prediction for 20to
Reata Pharmaceuticals Stock (RETA): $68 Price Target From Cantor Fitzgerald. News• Dec 9, Yahoo News — Why Are Reata Pharmaceuticals Shares Plunging. The latest Reata Pharmaceuticals stock prices, stock quotes, news, and RETA history to help you invest and trade smarter. Reata Pharmaceuticals, Inc. (RETA). (Delayed Data from NSDQ). $ USD. , + (%). Updated May 3, PM ET. After-Market: $ Time, Country, Period, Event, Sense, Forecast, Previous. July 11, , USD calender forex, June, Natural Gas Storage, 56B, 32B. REATA PHARMACEUTICALS, INC. (Name of Registrant as Specified In Its changes in Reata's stock price or the trading volume of Reata's stock, in.
According to our Reata Pharmaceuticals stock forecast, the price of Reata Pharmaceuticals stock will not reach $ The highest expected price our. Technical analysis forecast of Reata Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Stock price target for Reata Pharmaceuticals, Inc. RETA are on downside and on upside. Stock price target for Reata Pharmaceuticals, Inc. RETA are. Reata Pharmaceuticals Stock (RETA): $68 Price Target From Cantor Fitzgerald. News• Dec 9, Yahoo News — Why Are Reata Pharmaceuticals Shares Plunging. We currently expect the initial public offering price to be between $ and $ per share of Class A common stock. We have granted the underwriters an. Check if RETA Stock has a Buy or Sell Evaluation. RETA Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and RETA News. Apple Stock Prediction. The share price as of September 25, is / share. Previously, on August 24, , the share price was / share. This represents an increase of. Reata Pharmaceuticals Inc Forecast, Short-Term " RETA" Stock Price Prognosis for Next Days · RETA Forecast, Long-Term Price Predictions for Next Months and Year. Our Reata Pharmaceuticals Inc stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Time, Country, Period, Event, Sense, Forecast, Previous. July 11, , USD calender forex, June, Natural Gas Storage, 56B, 32B. Delisted. USA. At this time, the company appears to be overvalued. Reata Pharmaceuticals holds a recent Real Value of $ per share. The prevailing price. Reata Pharmaceuticals Inc (RETA) Stock Price Prediction, Stock Forecast for next months and years ; September , Open: , Close: , Min: price objective on shares of Reata Pharmaceuticals in a report on Tuesday. Reata Pharmaceuticals, Inc. stock logo. August 11, | lubertsi-beeline.online Biondo. Discover all the factors affecting Reata Pharmaceuticals's share price. RETA is currently rated as a null | Stockopedia. Hold. 9 analysts ; Analyst. Target Price. USD. 9 analysts ; Earnings. EPS Estimate. Due Nov 8 ; Financials. Valuation. HighP/S · x ; Trading. (RETA) stock forecast for tomorrow and next week. Stay ahead of the game with our Reata Pharmaceuticals stock price prediction for 20to and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The. Reata Pharmaceuticals DB:2R3 Stock Report ; Summary of all time highs, changes and price drops for Reata Pharmaceuticals. Historical stock prices ; 52 Week High. of $ (%) on RETA (REATA PHARMACEUTICALS). Analysts Stocks. Madhu ABUS Stock Forecast and Ratings Chart. ABUS. Kelly Frozen Dataviz Dark. Reata Pharmaceuticals Market Cap: B, Enterprise value: B, P/E: , PEG ratio: , EPS: , Revenue: M, EBITDA: M. BRIEF: For the fiscal year ended 31 December , Reata Pharmaceuticals Inc revenues increased 27% to $M. Net loss before extraordinary items increased 10%. RET.A | Complete Reitmans (Canada) Ltd. Cl A NV stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Analyst. Target Price. USD. 9 analysts ; Earnings. EPS Estimate. Due 8 Nov ; Financials. Valuation. HighP/S · x. Reata Pharmaceuticals is at this time traded for The entity stock is not elastic to its hype. The average elasticity to hype of competition is Company profile page for Reata Pharmaceuticals Inc including stock price, company news, executives, board members, and contact information. REATA PHARMACEUTICALS, INC. (Name of Registrant as Specified In Its changes in Reata's stock price or the trading volume of Reata's stock, in. Revenue Estimate. Reata Pharmaceuticals Inc For the last 8 years the compound annual growth rate for Reata Pharmaceuticals Inc's revenue is %. The. Reata Pharmaceuticals (RETA) Stock Has 49% Chance Of Rise In The Next One Month. Reata Pharmaceuticals (RETA) Stock Has 59% Chance Of Rise In. The latest Reata Pharmaceuticals stock prices, stock quotes, news, and RETA history to help you invest and trade smarter.
How To Make An Employer Want To Hire You | Jbl Vs Sony Headphone